Tanya Trakarnphornsombat
banner
watanyatra.bsky.social
Tanya Trakarnphornsombat
@watanyatra.bsky.social
Postdoctoral Training Fellow at the Institute of Cancer Research, London
Reposted by Tanya Trakarnphornsombat
So proud of Dan for winning the poster prize — and it was his very first poster! What a great start!
Congratulations to poster prize winners Daniel Price and Maximilian H. Fitz-James and @manthan5277.bsky.social . Sponsored by @gensocuk.bsky.social and cosponsored by the @biochemsoc.bsky.social
June 6, 2025 at 8:06 PM
Reposted by Tanya Trakarnphornsombat
The Transcription and Chromatin UK Meeting is back for 2025! Don't miss out — register your interest: www.biochemistry.org/events-and-t... @biochemsoc.bsky.social
Transcription and Chromatin UK 2025
Transcription and Chromatin UK brings together the rich transcription and epigenetics community in the UK and leading experts from abroad, and will feature all aspects of transcription and chromatin r...
www.biochemistry.org
April 1, 2025 at 11:36 AM
Reposted by Tanya Trakarnphornsombat
🚨 Preprint alert 🚨
Excited to share our work on "Ab-trapping," an antibody artifact causing misleading peripheral ("rim") staining in imaging & genomics (IF, CUT&Tag, CUT&RUN). Antibodies fail to penetrate structures, accumulating at the periphery. A 🧵👇
doi.org/10.1101/2025...
Ab-trapping - a peripheral staining artifact in antibody-based microscopy and genomics
Antibodies (Ab) are essential for detecting specific epitopes in microscopy and genomics, but can produce artifacts leading to erroneous interpretations. Here, we characterize a novel artifact, Ab-tra...
doi.org
April 14, 2025 at 8:08 PM
Reposted by Tanya Trakarnphornsombat
CRISPR genome editing clicks for amyloid cardiomyopathy.
nejm.org/doi/full/10.... A Phase 1 study with marked reduction of serum TTR
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy | NEJM
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, often fatal disease. Nexiguran ziclumeran (nex-z) is an investigational therapy based on CRISPR-Cas9 (clustered regularly i...
nejm.org
November 16, 2024 at 4:01 PM
Reposted by Tanya Trakarnphornsombat
Follow the Institute of Cancer Research on our new Bluesky account. Moving from X -
@icrlondon.bsky.social
November 14, 2024 at 8:05 AM